AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling

QR Code

AATF is Overexpressed in Human Head and Neck Squamous Cell Carcinoma and Regulates STAT3/Survivin Signaling

Lin Fu,1,2 Quanxiu Jin,3 Qianze Dong,1,2 Qingchang Li1,2 1Department of Pathology, College of Basic Medical Science, China Medical University, Shenyang, People’s Republic of China; 2Department of Pathology, The First Affiliated Hospital of China Medical University, Shenyang, People’s Republic of Chi...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Fu L, Jin Q, Dong Q, Li Q
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2021
Sujets:	aatf survivin stat3 head and neck squamous cell carcinoma Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/031f1b38f8824f8f9ea0ab86aefb9aa8
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
par: Xuanli Xu, et autres
Publié: (2021)

Current and Emerging Molecular Therapies for Head and Neck Squamous Cell Carcinoma
par: Farzaneh Kordbacheh, et autres
Publié: (2021)

Oral and Oropharyngeal Squamous Cell Carcinoma in Our Population: The Clinic-Pathological and Morphological Description of 153 Cases
par: Agarwal,A. K, et autres
Publié: (2011)

A Novel Pyroptosis-Related Gene Signature for Prognostic Prediction of Head and Neck Squamous Cell Carcinoma
par: Qian X, et autres
Publié: (2021)

Hypoxia-Targeting Multifunctional Nanoparticles for Sensitized Chemotherapy and Phototherapy in Head and Neck Squamous Cell Carcinoma
par: Song C, et autres
Publié: (2020)

Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
par: Philipp Baumeister, et autres
Publié: (2021)

Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
par: Shinsuke Suzuki, et autres
Publié: (2021)

Well-Differentiated Squamous Cell Carcinoma: Is Histological Differentiation a Relevant Prognostic Parameter?
par: Iago Ferreira, et autres
Publié: (2021)

The effect of red-allotrope selenium nanoparticles on head and neck squamous cell viability and growth
par: Hassan CE, et autres
Publié: (2016)

New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas
par: Cristina Porcheri, et autres
Publié: (2021)

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma
par: Xinwen Wang, et autres
Publié: (2021)

Imaging Features of Postradiotherapy Changes in Head and Neck Cancers
par: Anisha Gehani, et autres
Publié: (2021)

Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma
par: Xing-xing Huo, et autres
Publié: (2021)

Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery
par: Karl Payne, et autres
Publié: (2021)

Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review
par: Lucrezia Togni, et autres
Publié: (2021)

Rapid response of locally advanced oral squamous cell carcinoma to apatinib: A case report
par: He Jian, et autres
Publié: (2021)

Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas
par: Pei-Hung Chang, et autres
Publié: (2021)

Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
par: Ying-Peng Peng, et autres
Publié: (2021)

Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
par: Hayashi N, et autres
Publié: (2021)

Treatment Outcomes and the Safety of Chemoradiotherapy With High-Dose CDDP for Elderly Patients With Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Study
par: Jo Omata, et autres
Publié: (2021)

Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
par: Ammar Sukari, et autres
Publié: (2015)

Targeting miR-185-3p Inhibits Head and Neck Squamous Cell Carcinoma by Modulating RAB25
par: Xueping Wang, et autres
Publié: (2021)

A Novel Lipid Prognostic Signature of ADCY2, LIPE, and OLR1 in Head and Neck Squamous Cell Carcinoma
par: Xiaolei Gao, et autres
Publié: (2021)

Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma
par: Qi Sun, et autres
Publié: (2021)

Roles of mesenchymal stromal cells in the head and neck cancer microenvironment
par: Marcelo Coutinho de Miranda, et autres
Publié: (2021)

Prevalence of HPV in Mexican Patients with Head and Neck Squamous Carcinoma and Identification of Potential Prognostic Biomarkers
par: Galo Méndez-Matías, et autres
Publié: (2021)

The Hidden Link of Exosomes to Head and Neck Cancer
par: Yong Teng, et autres
Publié: (2021)

The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
par: Enhao Wang, et autres
Publié: (2021)

Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis
par: Jerry Polesel, et autres
Publié: (2021)

Factors associated with incomplete surgical margins in basal cell carcinoma of the head and neck
par: Fábio Muradás Girardi, et autres
Publié: (2021)

Review of oncological findings and complications after elective neck dissection during total laryngectomy: a case series
par: Mahmoud Elsayed, et autres
Publié: (2021)

The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define
par: Joanna Kozłowska, et autres
Publié: (2020)

EFFICACY OF INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
par: Muhammad Imran Khan Wajid, et autres
Publié: (2019)

Gene Mutations in Circulating Tumour DNA as a Diagnostic and Prognostic Marker in Head and Neck Cancer—A Systematic Review
par: Markéta Hudečková, et autres
Publié: (2021)

Rare Metastasis to the Submandibular Gland in Oral Squamous Cell Carcinoma
par: Ping Zhou, et autres
Publié: (2021)

IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells
par: Alena Gribko, et autres
Publié: (2021)

Indian journal of otolaryngology and head and neck surgery official publication of the Association of Otolaryngologists of India.
Publié: (1993)

Standardized Diagnostic Workup and Patient-Centered Decision Making for Surgery and Neck Dissection Followed by Risk-Factor Adapted Adjuvant Therapy Improve Loco-Regional Control in Local Advanced Oral Squamous Cell Carcinoma
par: Gunnar Wichmann, et autres
Publié: (2021)

Osteoradionecrosis in a Patient Submitted to Head and Neck Radiotherapy: A Case Report
par: Ferreira,Karla Daniella Malta, et autres
Publié: (2019)

A novel intronic circular RNA, circGNG7, inhibits head and neck squamous cell carcinoma progression by blocking the phosphorylation of heat shock protein 27 at Ser78 and Ser82
par: Houyu Ju, et autres
Publié: (2021)